Pomegra
Axon Enterprise (AXON) fell about 16% after Q3 2026 earnings missed estimates and the company trimmed its full-year revenue outlook to $3.61-$3.63 billion.
- Q3 revenue of $909 million and adjusted EPS of $1.72 both missed consensus.
- Three delayed federal Dedrone deployments, about $130 million, drove the cut.
- Axon also committed $1.2 billion to drone maker Skydio, lifting its stake to 37%.
Lead
Axon Enterprise (NASDAQ: AXON) shares dropped about 16% on Thursday, November 5, 2026, after the maker of Tasers, body cameras and public-safety software reported third-quarter results below Wall Street expectations and lowered its 2026 revenue forecast. Revenue rose 28% from a year earlier to $909 million, short of a consensus range of roughly $931 million to $940 million. Adjusted earnings of $1.72 per share fell short of an estimate near $1.90. Shares had traded as much as 18% lower before the open and extended losses the following day.What Happened in Axon's Third Quarter?
Axon posted record quarterly revenue, but growth and profit both came in under forecasts. Software and Services revenue rose 43% to $437 million, while Connected Devices revenue, which includes Tasers and body cameras, rose 16% to $472 million.
GAAP net income was $57 million, or $0.68 per diluted share. Non-GAAP net income was $144 million. Adjusted EBITDA rose more than 33% to $236 million, a margin of 25.9%.
Recurring metrics held up. Annual recurring revenue reached $1.75 billion, up 40%. Future contracted bookings stood at $15.8 billion, up 39%, and net revenue retention was 126%.
Why Did Axon Cut Its 2026 Outlook?
Axon cut its outlook because three large federal Dedrone counter-drone deployments, worth about $130 million in total, will not land in 2026. Slower government procurement cycles pushed them past the fiscal year.
Full-year revenue is now guided to $3.61 billion to $3.63 billion, about 30% growth, down from the prior 32% to 34%. The company said growth would have been roughly 500 basis points higher had those deployments stayed on schedule.
Other guidance moved as follows:
- Full-year adjusted EBITDA is projected at $924 million to $929 million, a margin of about 25.6%, up slightly from 25.5%.
- Free cash flow is projected at $350 million to $400 million, down from a prior target near $450 million.
- Fourth-quarter revenue is guided to $990 million to $1.01 billion, with adjusted EBITDA of $245 million to $250 million.
Why Did the Stock React So Sharply?
The stock reacted sharply because the shortfall hit a company priced for sustained high growth. The Dedrone delay is a timing issue rather than a loss of demand, but it raised questions about Axon's target of 30%-plus normalized bookings growth over five years. Several brokerages lowered their price targets after the report.
The reduced free cash flow outlook added pressure, as did the size of the new Skydio commitment. The decline was company-specific. Major U.S. indexes rose between 0.4% and 1.7% that day.
Strategic Context: The $1.2 Billion Skydio Bet
Alongside results, Axon announced a $1.2 billion investment in Skydio, funded through a mix of cash and stock. The deal raises Axon's ownership to 37% and makes it the exclusive U.S. and Canadian public-safety distributor for Skydio's drones.
CEO Rick Smith has described a future in which millions of drones operate across America within a decade. The strategy places Axon in direct competition with Motorola Solutions (MSI) in the public-safety technology market, pairing drones with its body-camera, evidence-management and real-time response software. The investment also raises Axon's capital commitments at a time when its free cash flow forecast has been reduced.
What Comes Next for Axon?
The next test is whether the delayed federal Dedrone deployments convert to revenue in 2027, and whether Software and Services growth near 43% can offset slower hardware timing. The fourth-quarter guidance implies a step up to roughly $1 billion in quarterly revenue. Procurement decisions by federal agencies and the pace of Skydio integration will shape the company's growth path.
Outlook
Axon enters the final quarter of 2026 with strong recurring revenue, a $15.8 billion contracted bookings base and a lower 2026 growth forecast. The share price decline reflects the reset in near-term expectations and the cost of the Skydio commitment rather than any weakening in underlying subscription demand. Execution on federal deployments and the drone strategy will determine whether the 30%-plus growth framework holds.
Mentioned tickers: AXON, MSI
